Abstract
Aim
This study compared dynamic thiol���disulfide homeostasis (an oxidative stress marker), anti-inflammatory interleukin-10 (IL-10) levels, and proinflammatory interferon gamma (IFN-γ) levels in drug-resistant epilepsy patients with those in patients with well-controlled epilepsy and healthy controls.
Method
This prospective cross-sectional study enrolled 89 people: 27 with drug-resistant epilepsy, 30 with well-controlled epilepsy, and 32 healthy controls matched in demographic characteristics.
Results
The mean serum IL-10 levels were significantly lower and the mean serum IFN-γ levels significantly higher in the drug-resistant epilepsy patients compared to the well-controlled epilepsy and healthy control groups. The mean serum native thiol (SH) and total thiol (TT) levels were significantly lower, and the disulfide (SS) levels were significantly higher in the drug-resistant group than in the other two groups.
Conclusions
The significant differences in thiol–disulfide homeostasis and IL-10 and IFN-γ levels in the drug-resistant epilepsy group suggest that these markers indicate a poor prognosis in epilepsy.
![](https://cdn.statically.io/img/media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10072-021-05331-x/MediaObjects/10072_2021_5331_Fig1_HTML.png)
![](https://cdn.statically.io/img/media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10072-021-05331-x/MediaObjects/10072_2021_5331_Fig2_HTML.png)
Similar content being viewed by others
References
Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CR (2010 May) Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia. 51(5):883–890
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1545-1602.
Devinsky O, Vezzani A, O'Brien TJ, Jette N, Scheffer IE, de Curtis M, Perucca P (2018 May 3) Epilepsy. Nat Rev Dis Primers 4:18024
Terrone G, Balosso S, Pauletti A, Ravizza T, Vezzani A (2020 May 1) Inflammation and reactive oxygen species as disease modifiers in epilepsy. Neuropharmacology. 167:107742
Pauletti A, Terrone G, Sheik-Ahmad T, Salamone A, Ravizza T, Rizzi M et al (2019 Jul 1) Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy. Brain. 142(7):e39
McElroy PB, Liang LP, Day BJ, Patel M (2017) Scavenging reactive oxygen species inhibits status epilepticus-induced neuroinflammation. Exp Neurol 298(Pt A):13–22
Erel O, Neselioglu S (2014 Dec) A novel and automated assay for thiol/disulfide homeostasis. Clin Biochem 47(18):326–332
Kurt ANC, Demir H, Aydin A, Erel Ö (2018 Jul) Dynamic thiol/disulphide homeostasis in children with febrile seizure. Seizure. 59:34–37
Bektas H, Vural G, Gumusyayla S, Deniz O, Alisik M, Erel O (2016 Dec) Dynamic thiol-disulfide homeostasis in acute ischemic stroke patients. Acta Neurol Belg 116(4):489–494
Gumusyayla S, Vural G, Bektas H, Neselioglu S, Deniz O, Erel O (2016 Aug) A novel oxidative stress marker in migraine patients: dynamic thiol-disulphide homeostasis. Neurol Sci 37(8):1311–1317
Gümüşyayla Ş, Vural G, Yurtoğulları Çevik Ş, Akdeniz G, Neselioğlu S, Deniz O, Erel Ö (2019 May) Dynamic thiol-disulphide homeostasis in patients with Guillain-Barre Syndrome. Neurol Res 41(5):413–418
Youn Y, Sung IK, Lee IG (2013 Jul) The role of cytokines in seizures: interleukin (IL)-1β, IL-1Ra, IL-8, and IL-10. Korean J Pediatr 56(7):271–274
de Vries EE, van den Munckhof B, Braun KP, van Royen-Kerkhof A, de Jager W, Jansen FE (2016 Apr) Inflammatory mediators in human epilepsy: a systematic review and meta-analysis. Neurosci Biobehav Rev 63:177–190
Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshé SL, Perucca E, Wiebe S, French J (2010 Jun) Definition of drug-resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 51(6):1069–1077
Martinc B, Grabnar I, Vovk T (2012 Dec) The role of reactive species in epileptogenesis and influence of antiepileptic drug therapy on oxidative stress. Curr Neuropharmacol 10(4):328–343
Löscher W. Epilepsy and alterations of the blood-brain barrier: cause or consequence of epileptic seizures or both? Handb Exp Pharmacol. 2020 Nov 3.
Kalilani L, Sun X, Pelgrims B, Noack-Rink M, Villanueva V (2018 Dec) The epidemiology of drug-resistant epilepsy: a systematic review and meta-analysis. Epilepsia. 59(12):2179–2193
Menon B, Ramalingam K, Kumar RV (2012 Dec) Oxidative stress in patients with epilepsy is independent of antiepileptic drugs. Seizure. 21(10):780–784
López J, González ME, Lorigados L, Morales L, Riverón G, Bauzá JY (2007 Mar) Oxidative stress markers in surgically treated patients with refractory epilepsy. Clin Biochem 40(5-6):292–298
Arhan E, Kurt ANC, Neselioglu S, Yerel O, Uçar HK, Aydin K, SERDAROGLU A (2019 Feb) Effects of antiepileptic drugs on dynamic thiol/disulphide homeostasis in children with idiopathic epilepsy. Seizure. 65:89–93
Kösem A (2020 Jun 14) Yücel Ç. Titiz AP, Sezer S, Neşelioğlu S, Erel Ö, et al. Evaluation of serum thiol-disulphide homeostasis parameters as oxidative stress markers in epilepsy patients. Acta Neurol Belg
Gümüşyayla Ş, Vural G, Bektaş H, Neşelioğlu S, Deniz O, Erel Ö (2016) Evaluation of dynamic thiol-disulphide homeostasis in patients with epilepsy. Epilepsi 22(3):86–92
Elmas B, Erel Ö, Ersavaş D, Yürümez Y (2017 Nov) Thiol/disulfide homeostasis as a novel indicator of oxidative stress in children with simple febrile seizures. Neurol Sci 38(11):1969–1975
Menon B, Ramalingam K, Kumar RV (2014 Oct) Low plasma antioxidant status in patients with epilepsy and the role of antiepileptic drugs on oxidative stress. Ann Indian Acad Neurol 17(4):398–404
Yang D, Elner SG, Bian ZM, Till GO, Petty HR, Elner VM (2007 Oct) Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells. Exp Eye Res 85(4):462–472
Vezzani A, Lang B, Aronica E (2015 Dec) Immunity and inflammation in epilepsy. Cold Spring Harb Perspect Med 18:6(2)
Strauss KI, Elisevich KV (2016 Oct 13) Brain region and epilepsy-associated differences in inflammatory mediator levels in medically refractory mesial temporal lobe epilepsy. J Neuroinflammation 13(1):270
Sun Y, Ma J, Li D, Li P, Zhou X, Li Y, He Z, Qin L, Liang L, Luo X (2019 Mar 28) Interleukin-10 inhibits interleukin-1β production and inflammasome activation of microglia in epileptic seizures. J Neuroinflammation 16(1):66
Basnyat P, Pesu M, Söderqvist M, Grönholm A, Liimatainen S, Peltola M, Raitanen J, Peltola J (2020 Jun 12) Chronically reduced IL-10 plasma levels are associated with hippocampal sclerosis in temporal lobe epilepsy patients. BMC Neurol 20(1):241
Kim K, Kwak BO, Kwon A, Ha J, Kim SJ, Bae SW, Son JS, Kim SN, Lee R (2017 Oct 10) Analysis of plasma multiplex cytokines and increased level of IL-10 and IL-1Ra cytokines in febrile seizures. J Neuroinflammation 14(1):200
Gao F, Gao Y, Zhang SJ, Zhe X, Meng FL, Qian H, Zhang B, Li YJ (2017 Jun) Alteration of plasma cytokines in patients with active epilepsy. Acta Neurol Scand 135(6):663–669
Li YJ, Wang ZH, Zhang B, Zhe X, Wang MJ, Shi ST, Bai J, Lin T, Guo CJ, Zhang SJ, Kong XL, Zuo X, Zhao H (2013 Jul 5) Disruption of the blood-brain barrier after generalized tonic-clonic seizures correlates with cerebrospinal fluid MMP-9 levels. J Neuroinflammation 10:80
Sudha K, Rao AV, Rao A (2001 Jan) Oxidative stress and antioxidants in epilepsy. Clin Chim Acta 303(1-2):19–24
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Mehtap Kocatürk and Adnan Kirmit. The first draft of the manuscript was written by Mehtap Kocatürk, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Bioethics Committee of the Medical Faculty of Harran University (No: 17/01/2019-E.2426).
Consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kocatürk, M., Kirmit, A. Evaluation of IL-10, IFN-γ, and thiol–disulfide homeostasis in patients with drug-resistant epilepsy. Neurol Sci 43, 485–492 (2022). https://doi.org/10.1007/s10072-021-05331-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-021-05331-x